89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
Abstract
Translate Article 
Take Notes
89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
ReferencesShowing 9 of 30 papers89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs Understanding Inter-Individual Variability in Monoclonal Antibody Disposition. Towards a knowledge-based Human Protein Atlas Determination of deoxymononucleotides and deoxynucleosides as a tool for toxicological examination--a trial for conversion of absorbance unit into molar amount in deoxydinucleotide. The processing and fate of antibodies and their radiolabels bound to the surface of tumor cells in vitro: a comparison of nine radiolabels. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies. Tissue-resident B cells orchestrate macrophage polarisation and function 89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo. Antibody Pharmacokinetics and Pharmacodynamics
4
- 10.3390/cancers15235546
- Nov 23, 2023
- Cancers
65
- 10.3390/antib8040056
- Dec 4, 2019
- Antibodies
2302
- 10.1038/nbt1210-1248
- Dec 1, 2010
- Nature Biotechnology
3
- 10.2131/jts.13.31
- Jan 1, 1988
- The Journal of Toxicological Sciences
149
- May 1, 1994
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
69
- 10.1007/s10928-016-9482-0
- Jul 4, 2016
- Journal of Pharmacokinetics and Pharmacodynamics
34
- 10.1038/s41467-023-42625-4
- Nov 4, 2023
- Nature Communications
52
- 10.2967/jnumed.118.224568
- May 30, 2019
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine
937
- 10.1002/jps.20178
- Nov 1, 2004
- Journal of Pharmaceutical Sciences
More from: EJNMMI ResearchCorrection: 89Zr-labeled ImmunoPET targeting the cancer stem cell antigen CD133 using fully-human antibody constructs Bimodality imaging as a companion to evaluate antitumour efficacy of TH-302 in experimental chondrosarcoma In vivo gastrin releasing peptide receptor expression in SDH deficient wild-type gastrointestinal stromal tumours (GIST): potential for theranostic applications A feasibility study of [18F] FDG PET/CT radiomics in predicting high-risk cytogenetic abnormalities in multiple myeloma Quantitative terbium-161 SPECT/CT imaging: demonstrating the feasibility of image-based dosimetry and highlighting pitfalls Staging lung cancer: total-body PET/CT or whole-body PET/CT? Hepatobiliary PET with [68Ga]Ga-BP-IDA – preclinical evaluation and its translational potential for liver function monitoring The impact of short-term non-steroidal androgen antagonist therapy on PSMA expression and tumor cellularity studied with dynamic [68Ga]Ga-PSMA-11 PET/MR in hormone-sensitive prostate cancer patients, a preliminary longitudinal prospective study Experience of [177Lu]Lu-PSMA-617-administration using totally implantable venous access port: simulated experiments and clinical SPECT analyses 89Zr-mAb uptake interpretation requires the use of tissue to plasma ratios corrected for antibody catabolism
- New
- Addendum
- 10.1186/s13550-025-01331-6
- Nov 4, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01322-7
- Oct 27, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01299-3
- Oct 21, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01321-8
- Oct 15, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01326-3
- Oct 13, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01317-4
- Oct 8, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01327-2
- Oct 2, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01328-1
- Oct 2, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01316-5
- Sep 26, 2025
- EJNMMI Research
- Research Article
- 10.1186/s13550-025-01315-6
- Sep 26, 2025
- EJNMMI Research
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.